BBS-Bioactive Bone Substitutes Oyj (HEL: BONEH)
0.305
-0.004 (-1.29%)
Aug 30, 2024, 6:29 PM EET
BONEH Company Description
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland.
It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle.
The company was incorporated in 1991 and is headquartered in Oulu, Finland.
BBS-Bioactive Bone Substitutes Oyj
Country | Finland |
Founded | 1991 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 24 |
CEO | Juliusz Rakowskias |
Contact Details
Address: Kiviharjunlenkki 6 Oulu, 90220 Finland | |
Phone | 358 4070 80307 |
Website | bbs-artebone.fi |
Stock Details
Ticker Symbol | BONEH |
Exchange | Nasdaq Helsinki |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | FI4000260583 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Juliusz Rakowskias | Chief Executive Officer |
Annastiina Kauppinen | Financial manager |
Paul C. Watkins | Chief Commercial Officer and Member of Advisory Board |